Swapped in for sugar, stevia lowers the after-meal blood sugar and insulin rise and holds body weight steady where sugar-sweetened drinks add weight. Appetite effects are unsettled. Blood-pressure lowering at much larger medicinal doses is reported by one research group and unconfirmed. The main practical hazard is the bulking agent packed alongside in most retail products. (Full Review)

Protocol

Sweetening use — dosed to taste

1–4 drops or one small scoop

Per beverage; a few milligrams of steviol equivalents, far below any threshold at which pharmacological effects appear.

Blood-pressure protocol — 250 to 500 mg three times daily

250–500 mg × 3 daily

Stevioside powder in capsules, the regimen used in the two Taiwanese trials — 250 mg over one year, 500 mg over two years.

Best time of day — with meals

Before lunch and dinner

Aligns exposure with the post-meal glucose rise; sweetening use follows whenever a sugar substitution occurs.

Time to effect

Post-meal glucose

First substituted meal

Sweetness is instant; post-meal glucose changes appear with the first substituted meal.

Body weight

12 weeks

Body weight differences took 12 weeks to emerge in trials.

Blood pressure

Within a week

Blood pressure changes appeared within a week at medicinal doses.

Benefits

High: Lower blood glucose and insulin response when substituted for sugar; body weight maintenance when displacing sugar-sweetened beverages

Medium: Lower two-year incidence of left ventricular hypertrophy; improved health-related quality of life on long-term stevioside

Low: Blood pressure reduction at pharmacologic stevioside doses; reduced cavity risk compared with sugar

Speculative: Direct enhancement of insulin secretion; antioxidant and anti-inflammatory organ protection

Contraindications

Documented allergic reaction to a stevia-containing product

Confirmed Asteraceae-family allergy (ragweed, chrysanthemum, chamomile) plus a prior reaction to crude leaf preparations

Medicinal doses (≥750 mg daily) on two or more antihypertensive drugs with resting systolic below 110 mmHg

Erythritol- or inulin-bulked blends in irritable bowel syndrome on a low-FODMAP diet

Pregnancy or breastfeeding above the acceptable daily intake (4 mg/kg daily of steviol equivalents)

Key Interactions

Antihypertensive drugs (amlodipine, lisinopril, losartan)

Glucose-lowering drugs (insulin, glipizide, glimepiride)

Lithium

Over-the-counter laxatives and magnesium antacids

Blood-sugar-lowering supplements (berberine, cinnamon extract, chromium picolinate, alpha-lipoic acid)

Blood-pressure-lowering supplements (beetroot or dietary nitrate, aged garlic extract, hibiscus, magnesium, CoQ10)

Risk & Side Effects

High: Digestive discomfort and dizziness at pharmacologic doses

Medium: Cardiometabolic risk from the erythritol used as a bulking agent; compensatory eating after sweet taste without calories

Low: Additive blood-pressure lowering in adults already treated for hypertension; allergic reaction in people sensitive to the daisy family; kidney stones made of steviol

Speculative: Shifts in gut and mouth bacterial communities; reproductive effects seen in high-dose animal work; genotoxic signals in some laboratory assays

Monitoring

Marker	Target	Why
Fasting glucose	75–86 mg/dL	Tracks the displaced sugar load
Glycated haemoglobin	4.8–5.3%	Average blood sugar over about three months
Fasting insulin	2–5 µIU/mL	Detects insulin resistance before glucose rises
Home systolic / diastolic blood pressure	110–120 / 70–79 mmHg	The endpoint the medicinal dose targets
Triglycerides	<80 mg/dL	Most sugar-responsive lipid fraction
Body weight and waist circumference	Waist <35 in (women) / <40 in (men)	Captures whether displaced calories return
eGFR with creatinine	>90 mL/min/1.73 m²	Steviol glucuronide is cleared by the kidneys
Plasma erythritol	No established target; track change from the individual's own baseline	Quantifies exposure from bulked products

Cadence: Blood pressure and weight every two weeks for eight weeks, then monthly; glucose, glycated haemoglobin, insulin, lipids and kidney function at three months, then every six to twelve months once values are stable.

Qualitative Assessment

Sweet cravings: whether the urge for sugar falls or intensifies over four to six weeks.
Digestive comfort: bloating, gas or loose stools, which usually track the bulking agent.
Energy stability: fewer mid-afternoon crashes after removing sugary drinks.

Stevia for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment